Valion Bio, Inc. (VBIO)
Nasdaq: VBIO · Electromedical & Electrotherapeutic Apparatus · San Antonio, TX · filing with the SEC since 2019
Who owns Valion Bio, Inc.
As filed with the SECHolders of 5% or more
2
Murchinson Ltd. holds 9.99% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13G filed Jul 17, 2026 says.
Directors and officers
9
report now, of 15 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Murchinson Ltd.
SCHEDULE 13G · filed Jul 17, 2026 · Common Stock, par value $0.0001 per share
3i, LP
SCHEDULE 13G/A · filed Sep 4, 2026 · Common Stock, par value $0.0001 per share · 9.9% in Sep 3, 2026
What VBIO reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Scorpius Holdings
A company bought · acquisition · owns, named in the 10-K filed Mar 30, 2026
Insider tradesForm 4
0sales
2purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 16 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Bolton Sheryle | director | 0 | $0 | 0 | 1 | $0 |
| Valauri Christina Rizopoulos | director | 0 | $0 | 0 | 1 | $0 |